Search results
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 7 days agoThe RS Rating measures a stock's 12-month running performance against all other stocks. That RS...
Pfizer’s 44% Decline In Profits Still Tops Estimates—Stock Bounces From Decade Low
Forbes· 7 days agoPfizer’s $0.55 diluted earnings per share and $14.9 billion in first...2024 guidance of $58.5...
Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To...
Benzinga via Yahoo Finance· 7 days agoThe company witnesses a significant decrease in Comirnaty and Paxlovid revenues globally and an...
People Are Sharing Just How Out Of Touch Their Boomer Parents Are
BuzzFeed via Yahoo News· 6 days agoI nearly lost all ability to walk, I live in pain, I fatigue easily, and my moods are all over the...
Who will RFK Jr. hurt more in 2024: Trump or Biden?
Yahoo News via AOL· 6 days ago12%); that vaccines cause autism (25% vs. 5%); and that chemicals in the water supply could...Kennedy and two other third-party candidates were added as...
With $15 minimum wage referendum looming, an Ohio Senate Republican offers a compromise
The Cleveland Plain Dealer· 6 days agoA Senate Republican is pitching a compromise to a proposed constitutional amendment that could make...
13 Best Stocks That Will Always Grow
Insider Monkey via Yahoo Finance· 15 hours agoIn this article, we discuss the 13 best stocks that will always grow. To skip the detailed analysis of the current economic landscape, go directly to the...
The Dow closes 300 points higher and the S&P 500 looks to break a losing streak as investors wait...
Quartz· 5 days agoAs the day ended, the Dow Jones Industrial Average gained 322 points, 0.85%, to trade at 38,225. The...
Rate of deadly STEMI heart attack falls among Americans
UPI· 5 days agoMany fewer Americans are falling prey to the most dangerous form of heart attack, a new study says.
Pfizer Earnings Top Views; Boosts Full-Year Guidance
Morningstar· 7 days agoBy Rob Curran Pfizer posted first-quarter earnings and sales that topped Wall Street targets and boosted its full-year projections as sales of blood thinners and cancer drugs helped shake off the hangover from its pandemic-era boom. The
